A number of patients with postviral syndrome after suspected COVID-19 have immune responses to SARS-CoV-2
Risks for Neurologic, Psychiatric Sequelae Persist After COVID-19
Adults have increased risks for cognitive deficit, dementia, psychotic disorders, epilepsy or seizures at two-year follow-up
Chronic Neuropsychiatric Symptoms Confirmed After COVID-19
Self-reported neurologic symptoms seem not to correlate with associated quantitative dysfunction
Neurologic Complications Common in Children Hospitalized With COVID-19
Presence of a neurologic complex chronic condition associated with higher odds for neurologic complications
Neurological Symptoms Persist After SARS-CoV-2 Infection
Memory impairment and decreased concentration most prevalent symptoms at six-month follow-up
Most Neurologic Symptoms Persist for COVID-19 Long Haulers
SARS-CoV-2 vaccination appears to have no positive or negative impact on cognitive function or fatigue
Serious Neurologic Manifestations Tied to Worse COVID-19 Outcomes
Encephalopathy was the most common serious neurologic manifestation, occurring in 10.2 percent of adults hospitalized with COVID-19
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered
Neurological, Neuropsychiatric Symptoms Common in COVID-19
Symptoms with the highest prevalence included anosmia, weakness, fatigue, dysgeusia, myalgia, and depression
- Page 1 of 2
- 1
- 2